Chemical company hit with $450 million penalty after contaminating public land for decades: 'We are hardly done'
Global manufacturing conglomerate 3M has bowed out of a historic environmental legal battle brought on by the state of New Jersey just days before the lawsuit's scheduled trial. This settlement is one of the largest wins a state has ever received to rectify damages to its land and natural resources, according to Inside Climate News.
Since March 2019, New Jersey has filed three lawsuits against 3M and simultaneous lawsuits against chemical giants DuPont and Chemours — the latter of which is a spinoff of the former.
Two of the three 3M lawsuits concerned the contamination of the state's natural resources near the Chambers Works sites, an active chemical plant that was previously operated by DuPont for gunpowder manufacturing and later by Chemours for dye and chemical production.
According to Manufacturing Dive, 3M was accused of supplying over 500,000 pounds of PFOA, a type of PFAS, to the Chambers Works site from the 1970s to 2002 for DuPont to use in its nonstick technology, Teflon. The manufacturing waste created during Teflon production was then allegedly discharged into the state's air, water, and soil surrounding the plant's site, contaminating natural resources with PFAS, which has large ramifications on public health and the environment.
PFAS are called "forever chemicals" because they can take up to hundreds or even thousands of years to break down. They leach into the soil and water supplies, which then get ingested by wildlife and humans, accumulating in our bodies' organs. Exposure to PFAS has been linked to disruptions in the endocrine system and mutations in gene expression, as well as increased risk of certain cancers and metabolic conditions.
3M's historic settlement with the state of New Jersey, a total compensation of $450 million for restoring the state's natural resources, marks a triumph in environmental conservation. This case sets the tone for ongoing litigation with DuPont and Chemours, in addition to other states looking to hold corporations accountable for their environmental impact.
"If you harm our residents, if you turn a profit at the expense of their interest and their health, if … you put the health and safety of our residents at risk — we're going to hold you accountable," said New Jersey Attorney General Matt Platkin, per Inside Climate News.
"We are hardly done. We will continue to hold DuPont, Chemours, and their progeny companies accountable. Expect that they come to the table or sit before a judge and jury," warned New Jersey Department of Environmental Protection Commissioner Shawn LaTourette, per Inside Climate News.
Do you feel safe drinking the tap water where you live?
Always
Most of the time
Not usually
Never
Click your choice to see results and speak your mind.
Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 hours ago
- Yahoo
Chemical company hit with $450 million penalty after contaminating public land for decades: 'We are hardly done'
Global manufacturing conglomerate 3M has bowed out of a historic environmental legal battle brought on by the state of New Jersey just days before the lawsuit's scheduled trial. This settlement is one of the largest wins a state has ever received to rectify damages to its land and natural resources, according to Inside Climate News. Since March 2019, New Jersey has filed three lawsuits against 3M and simultaneous lawsuits against chemical giants DuPont and Chemours — the latter of which is a spinoff of the former. Two of the three 3M lawsuits concerned the contamination of the state's natural resources near the Chambers Works sites, an active chemical plant that was previously operated by DuPont for gunpowder manufacturing and later by Chemours for dye and chemical production. According to Manufacturing Dive, 3M was accused of supplying over 500,000 pounds of PFOA, a type of PFAS, to the Chambers Works site from the 1970s to 2002 for DuPont to use in its nonstick technology, Teflon. The manufacturing waste created during Teflon production was then allegedly discharged into the state's air, water, and soil surrounding the plant's site, contaminating natural resources with PFAS, which has large ramifications on public health and the environment. PFAS are called "forever chemicals" because they can take up to hundreds or even thousands of years to break down. They leach into the soil and water supplies, which then get ingested by wildlife and humans, accumulating in our bodies' organs. Exposure to PFAS has been linked to disruptions in the endocrine system and mutations in gene expression, as well as increased risk of certain cancers and metabolic conditions. 3M's historic settlement with the state of New Jersey, a total compensation of $450 million for restoring the state's natural resources, marks a triumph in environmental conservation. This case sets the tone for ongoing litigation with DuPont and Chemours, in addition to other states looking to hold corporations accountable for their environmental impact. "If you harm our residents, if you turn a profit at the expense of their interest and their health, if … you put the health and safety of our residents at risk — we're going to hold you accountable," said New Jersey Attorney General Matt Platkin, per Inside Climate News. "We are hardly done. We will continue to hold DuPont, Chemours, and their progeny companies accountable. Expect that they come to the table or sit before a judge and jury," warned New Jersey Department of Environmental Protection Commissioner Shawn LaTourette, per Inside Climate News. Do you feel safe drinking the tap water where you live? Always Most of the time Not usually Never Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
Associated Press
11 hours ago
- Associated Press
Faruqi & Faruqi Reminds Organon Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between October 31, 2024 and April 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - June 7, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Organon & Co. ('Organon' or the 'Company') (NYSE: OGN) and reminds investors of the July 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See Defendants provided investors with material information concerning Organon's prioritization of its capital allocation strategy through regular, quarterly dividends. Defendants' statements included, among other things, reassurance that capital allocation through the aforementioned dividends was a "#1 capital allocation priority' and that Organon was committed to consistent deployment of capital. Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of the Company's priorities, particularly, related to capital allocation through quarterly dividends. Notably, Defendants concealed the high priority of Organon's debt reduction strategy following the Company's acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Organon's securities at artificially inflated prices. Investors and analysts again reacted promptly to Organon's revelations. The price of Organon's common stock declined dramatically. From a closing market price of $12.93 per share on April 30, 2025, Organon's stock price fell to $9.45 per share on May 1, 2025, a decline of more than 27% in the span of just a single day. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Organon's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Organon & Co. class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit
Associated Press
11 hours ago
- Associated Press
Faruqi & Faruqi Reminds Civitas Resources Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 1, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Civitas To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Civitas between February 27, 2024 and February 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - June 7, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Civitas Resources, Inc. ('Civitas' or the 'Company') (NYSE: CIVI) and reminds investors of the July 1, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. [ This image cannot be displayed. Please visit the source: ] Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Civitas was highly likely to significantly reduce its oil production in 2025 as a result of, inter alia, declines following the production peak at the DJ Basin in the fourth quarter of 2024 and a low TIL count at the end of 2024; (ii) increasing its oil production would require the Company to acquire additional acreage and development locations, thereby incurring significant debt and causing the Company to sell corporate assets to offset its acquisition costs; (iii) the Company's financial condition would require it to implement disruptive cost-reduction measures including a significant workforce reduction; (iv) accordingly, Civitas's business and/or financial prospects, as well as its operational capabilities, were overstated; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times. On February 24, 2025, Civitas released its fourth quarter and full year financial results, missing consensus estimates in revenue and non-GAAP EPS. The Company also announced a 10% reduction in its workforce across all levels and that its Chief Operating Officer and Chief Transformation Officer were both terminated, effective immediately. On this news, Civitas' stock price fell $8.95, or 18.2%, to close at $40.35 per share on February 25, 2025, thereby injuring investors. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding Civitas' conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the Civitas Resources class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit
